Historically shortstops are paid more than second basemen because of their value defensively. But Bichette could be an ...

Micron Technology forecast second-quarter adjusted profit at nearly double what Wall Street analysts expected on Wednesday, ...

Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) approved RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj), the first and only subcutaneously (SC) ...